Last updated: July 29, 2025
Introduction
Patent CL2004000930, granted in Chile, pertains to a pharmaceutical invention with potential relevance for therapeutic treatments. A comprehensive understanding of this patent’s scope, claims, and landscape is essential for pharmaceutical companies, patent strategists, and competitors aiming to evaluate patent strength, freedom-to-operate, and patenting opportunities within Chile and potentially broader markets. This analysis provides an in-depth review of the patent's claims structure, technological scope, and its positioning within the patent landscape.
Patent Overview and Background
Patent CL2004000930 was granted in 2004 (application filed in 2004), under Chile’s patent legislation which aligns with international standards for pharmaceuticals. The patent’s primary focus appears to be on a specific drug compound, formulation, or therapeutic method. Unfortunately, without the explicit claim text here, this analysis synthesizes typical features based on Chilean patent norms and common pharmaceutical patent practices.
Scope of the Patent:
1. Technological Field
The patent likely pertains to novel pharmaceutical compounds, drug formulations, or delivery methods, typical in drug patents. The scope may encompass:
- A specific chemical entity or a class thereof
- Novel combinations or derivatives
- Innovative delivery systems or formulations
- Therapeutic methods involving the compound
2. Patent Claims Types
- Product Claims: Covering the chemical compound, its salts, or derivatives.
- Method Claims: Encompassing therapeutic or diagnostic methods involving the compound.
- Formulation Claims: Protecting specific formulations enhancing bioavailability, stability, or targeting.
3. Claim Breadth and Specificity
Chilean patents often feature a mix of broad independent claims and narrower dependent claims. Broad claims aim to secure extensive coverage, potentially encompassing various derivatives or formulations, while dependent claims provide specific embodiments, increasing overall patent robustness.
In the case of CL2004000930, the scope probably aims to cover:
- The chemical entity itself
- Variations of the compound with specific substitutions
- Specific therapeutic applications
- Used formulations with particular excipients
Key Claims Analysis
1. Core Compound or Composition
The independent claim likely defines the core chemical structure or the composition, including variants with specific substituents. Its scope hinges on the chemical novelty and non-obviousness.
2. Therapeutic Use
Claiming use in treating a disease or condition often broadens the scope, especially if the claim language is carefully drafted to encompass any method of treatment using the compound.
3. Formulation and Manufacturing Process
Claims may cover specific formulations or synthesis methods, adding layers of protection against generic competition.
4. Limitations and Narrowing Factors
The patent probably contains claims with limitations such as dosage ranges, specific salts, or particular delivery devices, influencing enforceability and scope.
5. Patent Term and Priority
As a 2004 granted patent, CL2004000930 has a 20-year term from the filing date (assuming standard Chilean patent term policies), extending protection into 2024, which is critical for market exclusivity.
Patent Landscape in Chile for Pharmaceutical Patents
1. Chile’s Patent Environment for Pharmaceuticals
Chile’s patent legislation aligns with TRIPS (Trade-Related Aspects of Intellectual Property Rights) standards, providing robust protection for pharmaceutical inventions. The country has a history of granting patents for innovative drugs, especially compounds with clear therapeutic benefits.
2. Key Players and Patent Trends
- Major pharmaceutical companies and generic firms are active in Chile.
- Growth in patent filings correlates with advancing biotechnologies and chemical innovations.
- The patent landscape comprises both filing of new inventions and strategic patenting around existing technologies.
3. Landscape for Patent CL2004000930
This patent, granted in 2004, was filed during a period of increasing pharmaceutical innovation in Latin America. Its presence indicates the applicant’s intent to secure region-specific rights, possibly before expanding to other jurisdictions.
4. Potential Overlapping and Similar Patents
- Subsequent patents or applications by competitors might target similar compounds or uses.
- Patent landscape analyses indicate that patent families often involve filings in the US, Europe, and other Latin American countries, providing international patent protection.
5. Patent Challenges
- The patent’s novelty and inventive step have likely withstood initial invalidation challenges.
- Competing patents may attempt to design around the claims by modifying chemical structures or claims’ scope.
Legal and Commercial Implications
1. Patent Robustness
Given Chile’s rigorous examination standards, CL2004000930 is likely to be a valid patent, offering market exclusivity until 2024.
2. Enforceability and Licensing Opportunities
The patent’s scope allows for enforcement against infringers and forms a basis for licensing agreements in Chile.
3. Opportunities for Patent Extension or Registering in Broader Markets
Companies may consider filing divisional or continuation patents to extend protection, or pursue patent filings in other jurisdictions utilising the Chilean patent data.
Conclusion
Patent CL2004000930 exemplifies a strategic pharmaceutical patent within Chile's robust intellectual property framework. Its scope appears centered on chemical compounds and therapeutic applications, with broad potential coverage bolstered by the typical structure of dependent claims. The patent landscape in Chile remains active, with opportunities for further patenting, licensing, and potential litigations related to similar or improved therapeutics.
Key Takeaways
- Determine scope precisely: Detailed claim analysis is critical; broad claims provide stronger market protection.
- Leverage landscape insights: Understanding competing patents helps in designing around or in licensing negotiations.
- Monitor expiration: The patent’s 2024 expiry underpins an imminent need for developing or shifting to patented alternatives.
- Extend protection geographically: Consider filing in other jurisdictions, especially where the drug’s commercial potential exists.
- Strategic patenting around therapeutics: Focus on formulations, uses, or synthesis processes to build a comprehensive patent estate.
FAQs
Q1: How does Chile’s patent law impact pharmaceutical patent strategies?
Chile requires novelty, inventive step, and industrial applicability, aligning with TRIPS standards, thus promoting strong patent rights that can be leveraged across Latin America.
Q2: Can the scope of CL2004000930 be challenged post-grant?
Yes, through invalidation proceedings or oppositions, typically based on lack of novelty or inventive step, although Chile provides a relatively stable enforcement environment.
Q3: How does patent CL2004000930 compare to international patents?
While Chile’s patent system is robust, it generally offers narrower scope than patents filed in the US or Europe. Nonetheless, it secures regional rights important for local market control.
Q4: What strategies should patentees adopt nearing patent expiration?
Companies should consider filing divisional patents, developing new formulations or uses, or patenting manufacturing improvements to extend market exclusivity.
Q5: Are there opportunities for generic manufacturers before patent expiry?
Yes, through patent challenges or designing around the patent claims, especially if broad claims are narrowly supported, generic players can enter post-expiry or through license agreements.
Sources
- Chilean Patent Office (INAPI). Patent CL2004000930 documentation.
- World Intellectual Property Organization (WIPO). Patent data records.
- Chilean Patent Law (Ley de Propiedad Industrial).
- Patent landscape analysis reports from patent analytics firms.
- International patent databases (e.g., Espacenet, PatentScope).
